is there a patent on semaglutide New Delhi, March 19, 2026 – Friday, the key on semaglutide—the active molecule in Novo Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking pivotal shift in the country's Novo Nordisk says China court
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

)
























